about
Effect of Rosuvastatin on Bovine Pericardial Aortic Tissue Valve Calcification in a Rat Subdermal Implantation ModelSurgical management of coexisting coronary artery and valvular heart diseaseMultidisciplinary team approach for identifying potential candidate for transcatheter aortic valve implantationSurgical experience with infective endocarditis and aortic root abscess.Transcatheter aortic valve implantation in a patient with previous mitral valve replacement.Endovascular Repair versus Open Repair for Isolated Descending Thoracic Aortic Aneurysm.Efficacy of Goal-Directed Therapy Using Bioreactance Cardiac Output Monitoring after Valvular Heart Surgery.The Beneficial Effect of Renin-Angiotensin-Aldosterone System Blockade in Marfan Syndrome Patients after Aortic Root Replacement.The first korean patient with severe aortic stenosis and bilateral iliofemoral artery disease treated with transcatheter aortic valve implantation by transsubclavian approachOverexpression of transforming growth factor-beta 1 in the valvular fibrosis of chronic rheumatic heart disease.Clinical outcome of urgent coronary artery bypass graftingComparison of Early Clinical Results of Transcatheter versus Surgical Aortic Valve Replacement in Symptomatic High Risk Severe Aortic Stenosis Patients.Effect of Patient-Prosthesis Mismatch in Aortic Position on Late-Onset Tricuspid Regurgitation and Clinical Outcomes after Double Valve ReplacementPassion in Cardiothoracic Surgery in Korea: Remembering Professor Pill Whoon Hong, M.D.The First Case of Successful Transcatheter Aortic Valve Implantation Using CoreValve in Korea.Early Clinical Experience with Sutureless Aortic Valve Replacement for Severe Aortic Stenosis.Unmasked Obstructive Hypertrophic Cardiomyopathy after Mitral Valve Repair for Severe Mitral RegurgitationHistorical Perspectives of Korean Society for Thoracic and Cardiovascular Surgery: Inauguration and Activities of the Historical Records Preservation Committee
P50
Q33740831-B839623D-BAC3-4F1F-A196-7F9F4F8F3FE1Q33781910-DB780B9A-5444-4873-B7DD-354E5976A40EQ33941588-E5667C6C-4538-48D0-B8DF-83B88CEF5387Q33941594-308FFEB5-7295-4A5C-83A6-57F283D387D9Q34269659-1F30B659-503F-4CEF-994F-7348C4A3B9E7Q35778271-4A182F32-3C11-4D1C-98A2-E5744C9F02C0Q35778276-D3BE910D-DC8D-4FD5-B201-9BC3D6B0183AQ36418768-F2A61752-5C89-4D28-91D5-3B1F381C597FQ36457145-3F1F87D8-8D19-4910-A5EB-5F590D685CFDQ36854340-E26BF816-C29F-45D1-95F9-BB24D0A11E48Q37220360-DC74FBF6-D2A9-43D8-B139-D39107261C2FQ37261454-992CE6CA-0C27-4E51-89E9-926B4383A1C8Q41352378-F6F2E65E-1C4D-429E-8A54-E0089758544EQ42398169-9B21E495-B879-4CAD-8A5B-A46E9012EC23Q42404146-94408B49-4268-48A5-9189-CC0EA537CAD0Q49985108-AC27369D-37B2-4E3E-8342-F66A50AAA17AQ89872689-B09EB609-5161-4EE8-91ED-5308ACC48C46Q92566208-757C631F-943E-4685-B46B-DB75A8156029
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Byung-Chul Chang
@en
Byung-Chul Chang
@nl
type
label
Byung-Chul Chang
@en
Byung-Chul Chang
@nl
prefLabel
Byung-Chul Chang
@en
Byung-Chul Chang
@nl
P108
P31
P496
0000-0001-5005-8217